OMEICOS Therapeutics GmbH

OMEICOS Therapeutics’ is focused on developing therapeutics that can be broadly deployed in inflammatory, cardiovascular, ophthalmology and other disease indications using its proprietary technology and extensive knowledge of omega-3 fatty acid metabolism and biology. Learn more

Our pipeline of small molecules are first-in-class synthetic analogs of omega-3 fatty acid-derived metabolites that show up to 1,000-fold higher biological activity and significant improvement in pharmacokinetic properties compared to their natural counterparts.